The word for natural, programmed cell death — apoptosis — may not be a household word now, but neither was “DNA” when it was first coined. According to the 2009 Global Business Insights report on Apoptosis, targeting apoptosis pathways is not just good science. It’s big business.
With over 370 identified drugs in development aimed at apoptosis gene targets, including 27 radiosensitizers and chemosensitizers and 65 anti-inflammatories, the report correctly predicts the recent explosion in the apoptosis market. The $606 million market in 2008 has been growing exponentially and is ready to reach $12 billion in 2013.
By taking the stunning research available and creating the world’s first and only apoptogen formula, Apocaps®, Functional Nutriments is at the forefront of nutraceutical devleopment.